Ivermectin + Pyrantel Pamoate + Praziquantel

Verify with FDA CVM →

305 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
305
Total Reports
9
Deaths Reported
300.0%
Death Rate

Active Ingredients

Ivermectin + Pyrantel Pamoate + Praziquantel

Administration Routes

OralUnknown

Species Affected

Dog 305

Most Affected Breeds

Retriever - Labrador 52
Terrier - Yorkshire 18
Chihuahua 17
Crossbred Canine/dog 15
Boxer (German Boxer) 13
Beagle 11
Poodle (unspecified) 10
Retriever (unspecified) 9
Terrier (unspecified) 9
Shepherd Dog - German 9

Most Reported Reactions

Emesis 97
Lack of efficacy (endoparasite) - heartworm 55
Vomiting 35
INEFFECTIVE, HEARTWORM LARVAE 32
Lethargy (see also Central nervous system depression in 'Neurological') 30
Lack of efficacy (ectoparasite) - flea 25
Seizure NOS 15
Diarrhoea 14
Lack of efficacy - NOS 13
Emesis (multiple) 13
Other abnormal test result NOS 13
Behavioural disorder NOS 11

Outcome Breakdown

Recovered/Normal
137 (44.9%)
Outcome Unknown
118 (38.7%)
Ongoing
23 (7.5%)
Recovered with Sequela
18 (5.9%)
Died
7 (2.3%)
Euthanized
2 (0.7%)

Data Summary

Metric Value
Total adverse event reports 305
Reports involving death 9
Case-fatality rate (reported events) 300.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin + Pyrantel Pamoate + Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 305 adverse event reports referencing Ivermectin + Pyrantel Pamoate + Praziquantel, including 9 reports in which the animal died — a 300.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin + Pyrantel Pamoate + Praziquantel. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin + Pyrantel Pamoate + Praziquantel reports are Dog (305 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (52), Terrier - Yorkshire (18), Chihuahua (17) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin + Pyrantel Pamoate + Praziquantel are Emesis (97), Lack of efficacy (endoparasite) - heartworm (55), Vomiting (35), INEFFECTIVE, HEARTWORM LARVAE (32). Of the 305 reports with a coded outcome, Recovered/Normal is the leading category at 44.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin + Pyrantel Pamoate + Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial